Stereotactic Body Radiation Therapy Versus Nonradiotherapeutic Ablative Procedures (Laser/Cryoablation and Electrocautery) for Early-Stage Non-Small Cell Lung Cancer

被引:19
作者
Baine, Michael J. [1 ]
Sleightholm, Richard [2 ,3 ]
Neilsen, Beth K. [4 ]
Oupicky, David [2 ]
Smith, Lynette M. [3 ]
Verma, Vivek [5 ]
Lin, Chi [1 ]
机构
[1] Univ Nebraska Med Ctr, Dept Radiat Oncol, Fred & Pamela Buffett Canc Ctr, 987521 Nebraska Med Ctr, Omaha, NE 68198 USA
[2] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Coll Publ Hlth, Omaha, NE 68198 USA
[3] Univ Nebraska Med Ctr, Dept Biostat, Coll Publ Hlth, Omaha, NE 68198 USA
[4] Univ Nebraska Med Ctr, Eppley Inst, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA
[5] Allegheny Gen Hosp, Dept Radiat Oncol, Pittsburgh, PA 15212 USA
来源
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2019年 / 17卷 / 05期
关键词
MEDICALLY INOPERABLE PATIENTS; INTENTION-TO-TREAT; RADIOFREQUENCY ABLATION; RADIOTHERAPY; TUMORS; PHASE-2; TRIAL;
D O I
10.6004/jnccn.2018.7269
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Despite the fact that stereotactic body radiation therapy (SBRT) is the only recommended first-line therapy for inoperable early-stage non-small cell lung cancer (NSCLC), several thermal ablative procedures (TAPs; defined herein as laser/cryoablation and electrocautery) are available. Studies showing outcomes of these procedures and how they compare with SBRT are scarce. We sought to evaluate the comparative efficacy of SBRT versus TAPs using the National Cancer Database (NCDB). Methods: The NCDB was queried for patients with early-stage NSCLC who did not undergo surgical resection. Treatment-specific inclusion criteria were applied to select for patients receiving either TAPs or SBRT. Univariate logistic regression and Cox proportional hazards modeling were performed, and Kaplan-Meier curves were generated. Serial propensity matches were performed using a modified greedy 8 -> n matching 1:1 algorithm. Results: A total of 27,734 patients were analyzed; 26,725 underwent SBRT and 1,009 underwent TAPs. Patients who received SBRT were older and more likely to have clinical stage IB (vs IA) disease. Despite this, SBRT was associated with longer median overall survival (mOS; 37.7 vs 33.5 months; P=.001) and 1-, 2-, and 5-year OS rates compared with the TAPs cohort (86.7% vs 83.1%, 67.5% vs 62.7%, and 30.6% vs 26.9%, respectively; P=.001). Upon propensity matching, improved OS with SBRT remained, with a mOS of 40.4 versus 33.4 months and 1-, 2-, and 5-year OS rates of 89.0% versus 82.9%, 69.7% versus 62.7%, and 34.4% versus 26.4%, respectively (P=.003). Conclusions: Despite being associated with more higher-risk factors, SBRT was associated with higher OS compared with TAPs for treatment of nonoperative patients diagnosed with early-stage NSCLC. However, causation cannot be implied owing to the inherent limitations of large heterogeneous datasets such as the NCDB.
引用
收藏
页码:450 / 458
页数:9
相关论文
共 26 条
[1]   Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer [J].
Ambrogi, Marcello C. ;
Fanucchi, Olivia ;
Dini, Paolo ;
Melfi, Franca ;
Davini, Federico ;
Lucchi, Marco ;
Massimetti, Gabriele ;
Mussi, Alfredo .
EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (04) :1089-1097
[2]   Long-Term Results of Radiofrequency Ablation Treatment of Stage I Non-small Cell Lung Cancer A Prospective Intention-to-Treat Study [J].
Ambrogi, Marcello Carlo ;
Fanucchi, Olivia ;
Cioni, Roberto ;
Dini, Paolo ;
De Liperi, Annalisa ;
Cappelli, Carla ;
Davini, Federico ;
Bartolozzi, Carlo ;
Mussi, Alfredo .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) :2044-2051
[3]   Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial [J].
Ball, David ;
Mai, G. Tao ;
Vinod, Shalini ;
Babington, Scott ;
Ruben, Jeremy ;
Kron, Tomas ;
Chesson, Brent ;
Herschtal, Alan ;
Vanevski, Marijana ;
Rezo, Angela ;
Elder, Christine ;
Skala, Marketa ;
Wirth, Andrew ;
Wheeler, Greg ;
Lim, Adeline ;
Shaw, Mark ;
Schofield, Penelope ;
Irving, Louis ;
Solomon, Benjamin .
LANCET ONCOLOGY, 2019, 20 (04) :494-503
[4]   Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis [J].
Bi, Nan ;
Shedden, Kerby ;
Zheng, Xiangpeng ;
Kong, Feng-Ming .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 95 (05) :1378-1390
[5]   The National Cancer Data Base: A powerful initiative to improve cancer care in the United States [J].
Bilimoria, Karl Y. ;
Stewart, Andrew K. ;
Winchester, David P. ;
Ko, Clifford Y. .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (03) :683-690
[6]   Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer [J].
Brooks, Eric D. ;
Sun, Bing ;
Feng, Lei ;
Verma, Vivek ;
Zhao, Lina ;
Gomez, Daniel R. ;
Liao, Zhongxing ;
Jeter, Melenda ;
O'Reilly, Michael ;
Welsh, James W. ;
Quynh-Nhu Nguyen ;
Erasmus, Jeremy J. ;
Eapen, George ;
Ahrar, Kamran ;
Antonoff, Mara B. ;
Hahn, Stephen M. ;
Heymach, John, V ;
Rice, David C. ;
Chang, Joe Y. .
JAMA NETWORK OPEN, 2018, 1 (04)
[7]   Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials [J].
Chang, Joe Y. ;
Senan, Suresh ;
Paul, Marinus A. ;
Mehran, Reza J. ;
Louie, Alexander V. ;
Balter, Peter ;
Groen, Harry J. M. ;
McRae, Stephen E. ;
Widder, Joachim ;
Feng, Lei ;
van den Borne, Ben E. E. M. ;
Munsell, Mark F. ;
Hurkmans, Coen ;
Berry, Donald A. ;
van Werkhoven, Erik ;
Kresl, John J. ;
Dingemans, Anne-Marie ;
Dawood, Omar ;
Haasbeek, Cornelis J. A. ;
Carpenter, Larry S. ;
De Jaeger, Katrien ;
Komaki, Ritsuko ;
Slotman, Ben J. ;
Smit, Egbert F. ;
Roth, Jack A. .
LANCET ONCOLOGY, 2015, 16 (06) :630-637
[8]   Lung Cancer Ablation: What Is the Evidence? [J].
de Baere, Thierry ;
Farouil, Geoffroy ;
Deschamps, Frederic .
SEMINARS IN INTERVENTIONAL RADIOLOGY, 2013, 30 (02) :151-156
[9]   Radiofrequency Ablation of Stage IA Non-Small Cell Lung Cancer in Medically Inoperable Patients: Results From the American College of Surgeons Oncology Group Z4033 (Alliance) Trial [J].
Dupuy, Damian E. ;
Fernando, Hiran C. ;
Hillman, Shauna ;
Ng, Thomas ;
Tan, Angelina D. ;
Sharma, Amita ;
Rilling, William S. ;
Hong, Kelvin ;
Putnam, Joe B. .
CANCER, 2015, 121 (19) :3491-3498
[10]   Stereotactic body radiation therapy versus conventionally fractionated radiation therapy for early stage non-small cell lung cancer [J].
Haque, Waqar ;
Verma, Vivek ;
Polamraju, Praveen ;
Farach, Andrew ;
Butler, E. Brian ;
Teh, Bin S. .
RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) :264-269